Evidence map›Paper›PMID 26530134›Full record

ArticleMucosal immunology2016

Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis.

R Mora-Buch, I Dotti, N Planell, E Calderón-Gómez, P Jung, M C Masamunt, J Llach, E Ricart, E Batlle, J Panés and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

R Mora-BuchDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
I DottiDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
N PlanellDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
E Calderón-GómezDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
P JungOncology Program, Institute for Research in Biomedicine Barcelona (IRB Barcelona), Barcelona, Spain.
M C MasamuntDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
J LlachEndoscopy Unit, Hospital Clínic, CIBERehd, Barcelona, Spain.
E RicartDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
E BatlleOncology Program, Institute for Research in Biomedicine Barcelona (IRB Barcelona), Barcelona, Spain.
J PanésDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
A SalasDepartment of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínic de Barcelona · ESInstitute for Research in Biomedicine · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis (UC) is a chronic intestinal inflammatory disease that may undergo periods of activity followed by remission. We aimed to identify the endogenous regulatory mechanisms that may promote disease remission. Transcriptional and protein analysis of the intestinal mucosa revealed that the IL-1 decoy receptor, interleukin-1 receptor type 2 (IL1R2), was upregulated in remission compared with active UC and controls. We identified epithelial cells as being responsible for increased IL-1R2 production during remission. Expression of IL1R2 was negatively regulated by Wnt/beta-catenin signals in colonic crypts or epithelial stem cell cultures; accordingly, epithelial stem cells upregulated IL-1R2 upon differentiation. Blocking IL-1R2 in isolated colonic crypt cultures of UC patients in remission and T-cell cultures stimulated with biopsy supernatant from UC patients in remission boosted IL-1β-dependent production of inflammation-related cytokines. Finally, IL1R2 transcription was significantly lower in patients that relapsed during a 1-year follow-up period compared with those in endoscopic remission. Collectively, our results reveal that the IL-1/IL-1R2 axis is differentially regulated in the remitting intestinal mucosa of UC patients. We hypothesize that IL-1R2 in the presence of low concentrations of IL-1β may act locally as a regulator of intestinal homeostasis.

Indexed as

AdultAgedbeta CateninCells, CulturedColitis, UlcerativeFemaleFollow-Up StudiesHomeostasisHumansInterleukin-1betaIntestinal MucosaMaleMiddle AgedReceptors, Interleukin-1 Type IIRemission, SpontaneousSignal Transductionbeta CateninIL1R2 protein, humanInterleukin-1betaReceptors, Interleukin-1 Type IIWnt Proteins

Identifiers

PMID26530134
PMCPMC4917674
OpenAlexW2460953327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.